66 - Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study
episode
TMO EPM / Hemato H9J
not yet transcribed
Transcript
This episode hasn't been transcribed yet
Upvotes decide what gets transcribed next — 0 so far.
Sign in to upvote
Related
recent transcribed audio
Finance and Budget Committee - Sep 15, 2026
The Art of True Happiness | Dr. Arthur Brooks
The Chris Wolfe Podcast: The Power of Quality Supplements
Guenther Steiner's 2026 Madrid GP Recap! | Vankah Hours S3E18
1208: TM Europe win the '26 Solheim Cup
MORNING TEA: Harry & Meghan's Brutal SNL Roast, Lady Gaga's Baby News & Dakota Johnson's New Man